Skip to main content
Top
Published in: BMC Geriatrics 1/2024

Open Access 01-12-2024 | Type 2 Diabetes | Research

Correlation between fat-to-muscle mass ratio and cognitive impairment in elderly patients with type 2 diabetes mellitus: a cross-sectional study

Authors: Fan Wu, Yanlan Liu, Chenying Lin, Nahal Haghbin, Longfei Xia, Yaoshuang Li, Tong Chen, Huina Qiu, Weiran Jiang, Jingbo Li, Jingna Lin

Published in: BMC Geriatrics | Issue 1/2024

Login to get access

Abstract

Background

Fat to muscle mass ratio (FMR), a novel index integrating fat and muscle composition, has garnered attention in age-related conditions such as type 2 diabetes mellitus (T2DM) and neurodegenerative diseases. Despite this research on the relationship between FMR and cognitive impairment (CI) in T2DM remains scarce. This study aimed to investigate the sex-specific association between FMR and CI in elderly T2DM patients.

Methods

A total of 768 elderly (> 60 years) T2DM in-patients (356 men and 412 women) were recruited from the Department of Endocrinology at Tianjin Nankai University affiliated hospital. Bioelectrical Impedance Analysis (BIA) was used to assess body composition, and Montreal Cognitive Assessment (MoCA) was used to evaluate cognitive performance. T2DM patients were categorized into normal cognitive function (NC) and cognitive impairment (CI) groups based on MoCA scores and stratified by sex. Binary logistic regression was employed to examine the association between FMR and CI.

Results

Among the participants, 42.7% of men and 56.3% of women experienced cognitive deterioration. Women with CI exhibited lower body mass index (BMI) and skeletal muscle mass index (SMI), while men with cognitive disorders showed lower SMI, FMR, and higher fat mass index (FMI). FMR was consistently unrelated to cognition in females, irrespective of adjustment made. However, in males, FMR was significantly associated with an increasing risk of cognitive dysfunction after adjusting for demographic and clinical variables (OR: 1.175, 95% CI: 1.045–1.320, p = 0.007). Furthermore, for each 0.1 increase in FMR, the incidence of CI rose by 31.1% after additional adjustment for BMI. In males, the prevalence of CI increased sequentially across FMR quartiles (p < 0.05).

Conclusion

Elderly T2DM men with high FMR had unfavorable cognitive function. FMR is independently associated with an increased risk of CI in male T2DM patients regardless of BMI.
Literature
1.
go back to reference Jia L, Du Y, Chu L, Zhang Z, Li F, Lyu D, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health. 2020;5(12):e661–71.CrossRefPubMed Jia L, Du Y, Chu L, Zhang Z, Li F, Lyu D, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health. 2020;5(12):e661–71.CrossRefPubMed
2.
go back to reference Frison E, Dufouil C, Helmer C, Berr C, Auriacombe S, Chêne G. Diabetes-Associated Dementia Risk and competing risk of death in the three-city study. J Alzheimers Dis. 2019;71(4):1339–50.CrossRefPubMed Frison E, Dufouil C, Helmer C, Berr C, Auriacombe S, Chêne G. Diabetes-Associated Dementia Risk and competing risk of death in the three-city study. J Alzheimers Dis. 2019;71(4):1339–50.CrossRefPubMed
3.
go back to reference Haroon NN, Austin PC, Shah BR, Wu J, Gill SS, Booth GL. Risk of dementia in seniors with newly diagnosed diabetes: a population-based study. Diabetes Care. 2015;38(10):1868–75.CrossRefPubMed Haroon NN, Austin PC, Shah BR, Wu J, Gill SS, Booth GL. Risk of dementia in seniors with newly diagnosed diabetes: a population-based study. Diabetes Care. 2015;38(10):1868–75.CrossRefPubMed
4.
go back to reference Munshi MN. Cognitive dysfunction in older adults with diabetes: what a Clinician needs to know. Diabetes Care. 2017;40(4):461–7.CrossRefPubMed Munshi MN. Cognitive dysfunction in older adults with diabetes: what a Clinician needs to know. Diabetes Care. 2017;40(4):461–7.CrossRefPubMed
5.
go back to reference Malone JI, Hansen BC. Does obesity cause type 2 diabetes mellitus (T2DM)? Or is it the opposite? Pediatr Diabetes. 2019;20(1):5–9.CrossRefPubMed Malone JI, Hansen BC. Does obesity cause type 2 diabetes mellitus (T2DM)? Or is it the opposite? Pediatr Diabetes. 2019;20(1):5–9.CrossRefPubMed
6.
go back to reference Mallorquí-Bagué N, Lozano-Madrid M, Toledo E, Corella D, Salas-Salvadó J, Cuenca-Royo A, et al. Type 2 diabetes and cognitive impairment in an older population with overweight or obesity and metabolic syndrome: baseline cross-sectional analysis of the PREDIMED-plus study. Sci Rep. 2018;8(1):16128.CrossRefPubMedPubMedCentral Mallorquí-Bagué N, Lozano-Madrid M, Toledo E, Corella D, Salas-Salvadó J, Cuenca-Royo A, et al. Type 2 diabetes and cognitive impairment in an older population with overweight or obesity and metabolic syndrome: baseline cross-sectional analysis of the PREDIMED-plus study. Sci Rep. 2018;8(1):16128.CrossRefPubMedPubMedCentral
7.
go back to reference Noh HM, Han J, Kim YJ, Jung JH, Roh YK, Song HJ. Sex differences in the relationship between cognitive impairment and overweight or obesity in late life: a 3-year prospective study. Med (Baltim). 2019;98(9):e14736.CrossRef Noh HM, Han J, Kim YJ, Jung JH, Roh YK, Song HJ. Sex differences in the relationship between cognitive impairment and overweight or obesity in late life: a 3-year prospective study. Med (Baltim). 2019;98(9):e14736.CrossRef
8.
go back to reference Thibeau S, McDermott K, McFall GP, Rockwood K, Dixon RA. Frailty effects on non-demented cognitive trajectories are moderated by sex and Alzheimer’s genetic risk. Alzheimers Res Ther. 2019;11(1):55.CrossRefPubMedPubMedCentral Thibeau S, McDermott K, McFall GP, Rockwood K, Dixon RA. Frailty effects on non-demented cognitive trajectories are moderated by sex and Alzheimer’s genetic risk. Alzheimers Res Ther. 2019;11(1):55.CrossRefPubMedPubMedCentral
9.
go back to reference Auyeung TW, Lee JS, Leung J, Kwok T, Woo J. Adiposity to muscle ratio predicts incident physical limitation in a cohort of 3,153 older adults–an alternative measurement of Sarcopenia and sarcopenic obesity. Age (Dordr). 2013;35(4):1377–85.CrossRefPubMed Auyeung TW, Lee JS, Leung J, Kwok T, Woo J. Adiposity to muscle ratio predicts incident physical limitation in a cohort of 3,153 older adults–an alternative measurement of Sarcopenia and sarcopenic obesity. Age (Dordr). 2013;35(4):1377–85.CrossRefPubMed
10.
go back to reference Lee HS, Kim SG, Kim JK, Lee YK, Noh JW, Oh J, et al. Fat-to-lean Mass ratio can predict cardiac events and all-cause mortality in patients undergoing hemodialysis. Ann Nutr Metab. 2018;73(3):241–9.CrossRefPubMed Lee HS, Kim SG, Kim JK, Lee YK, Noh JW, Oh J, et al. Fat-to-lean Mass ratio can predict cardiac events and all-cause mortality in patients undergoing hemodialysis. Ann Nutr Metab. 2018;73(3):241–9.CrossRefPubMed
11.
go back to reference Seo YG, Song HJ, Song YR. Fat-to-muscle ratio as a predictor of insulin resistance and metabolic syndrome in Korean adults. J Cachexia Sarcopenia Muscle. 2020;11(3):710–25.CrossRefPubMedPubMedCentral Seo YG, Song HJ, Song YR. Fat-to-muscle ratio as a predictor of insulin resistance and metabolic syndrome in Korean adults. J Cachexia Sarcopenia Muscle. 2020;11(3):710–25.CrossRefPubMedPubMedCentral
12.
go back to reference Ma W, Zhang H, Wu N, Liu Y, Han P, Wang F, et al. Relationship between obesity-related anthropometric indicators and cognitive function in Chinese suburb-dwelling older adults. PLoS ONE. 2021;16(10):e0258922.CrossRefPubMedPubMedCentral Ma W, Zhang H, Wu N, Liu Y, Han P, Wang F, et al. Relationship between obesity-related anthropometric indicators and cognitive function in Chinese suburb-dwelling older adults. PLoS ONE. 2021;16(10):e0258922.CrossRefPubMedPubMedCentral
13.
go back to reference Wang W, Luo Y, Zhuang Z, Song Z, Huang N, Li Y, et al. Total and regional fat-to-muscle mass ratio and risks of incident all-cause dementia, Alzheimer’s disease, and vascular dementia. J Cachexia Sarcopenia Muscle. 2022;13(5):2447–55.CrossRefPubMedPubMedCentral Wang W, Luo Y, Zhuang Z, Song Z, Huang N, Li Y, et al. Total and regional fat-to-muscle mass ratio and risks of incident all-cause dementia, Alzheimer’s disease, and vascular dementia. J Cachexia Sarcopenia Muscle. 2022;13(5):2447–55.CrossRefPubMedPubMedCentral
14.
go back to reference Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–53.CrossRefPubMed Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–53.CrossRefPubMed
15.
go back to reference Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.CrossRefPubMed Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.CrossRefPubMed
16.
go back to reference Tsoi KK, Chan JY, Hirai HW, Wong SY, Kwok TC. Cognitive tests to detect dementia: a systematic review and Meta-analysis. JAMA Intern Med. 2015;175(9):1450–8.CrossRefPubMed Tsoi KK, Chan JY, Hirai HW, Wong SY, Kwok TC. Cognitive tests to detect dementia: a systematic review and Meta-analysis. JAMA Intern Med. 2015;175(9):1450–8.CrossRefPubMed
17.
go back to reference Jia W, Weng J, Zhu D, Ji L, Lu J, Zhou Z, et al. Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev. 2019;35(6):e3158.CrossRefPubMed Jia W, Weng J, Zhu D, Ji L, Lu J, Zhou Z, et al. Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev. 2019;35(6):e3158.CrossRefPubMed
18.
go back to reference [Expert consensus of the. Diagnosis and treatment measures for the Chinese elderly patients with type 2 diabetes (2018 Edition)]. Zhonghua Nei Ke Za Zhi. 2018;57(9):626–41. [Expert consensus of the. Diagnosis and treatment measures for the Chinese elderly patients with type 2 diabetes (2018 Edition)]. Zhonghua Nei Ke Za Zhi. 2018;57(9):626–41.
19.
go back to reference Low S, Goh KS, Ng TP, Moh A, Ang SF, Khoo J, et al. Decline in skeletal muscle mass is associated with cognitive decline in type 2 diabetes mellitus. J Diabetes Complications. 2022;36(9):108258.CrossRefPubMed Low S, Goh KS, Ng TP, Moh A, Ang SF, Khoo J, et al. Decline in skeletal muscle mass is associated with cognitive decline in type 2 diabetes mellitus. J Diabetes Complications. 2022;36(9):108258.CrossRefPubMed
20.
go back to reference Sugimoto T, Kuroda Y, Matsumoto N, Uchida K, Kishino Y, Saji N, et al. Cross-sectional associations of Sarcopenia and its components with neuropsychological performance among memory clinic patients with mild cognitive impairment and Alzheimer’s Disease. J Frailty Aging. 2022;11(2):182–9.PubMed Sugimoto T, Kuroda Y, Matsumoto N, Uchida K, Kishino Y, Saji N, et al. Cross-sectional associations of Sarcopenia and its components with neuropsychological performance among memory clinic patients with mild cognitive impairment and Alzheimer’s Disease. J Frailty Aging. 2022;11(2):182–9.PubMed
21.
go back to reference Batsis JA, Haudenschild C, Roth RM, Gooding TL, Roderka MN, Masterson T, et al. Incident impaired cognitive function in sarcopenic obesity: data from the National Health and Aging trends Survey. J Am Med Dir Assoc. 2021;22(4):865–e725.CrossRefPubMed Batsis JA, Haudenschild C, Roth RM, Gooding TL, Roderka MN, Masterson T, et al. Incident impaired cognitive function in sarcopenic obesity: data from the National Health and Aging trends Survey. J Am Med Dir Assoc. 2021;22(4):865–e725.CrossRefPubMed
22.
go back to reference Heisey HD, Kunik ME, Qualls C, Segoviano-Escobar MB, Villareal DT. Truncal Fat and Frailty are important predictors of cognitive performance among aging adults with obesity. J Nutr Health Aging. 2022;26(5):425–9.CrossRefPubMedPubMedCentral Heisey HD, Kunik ME, Qualls C, Segoviano-Escobar MB, Villareal DT. Truncal Fat and Frailty are important predictors of cognitive performance among aging adults with obesity. J Nutr Health Aging. 2022;26(5):425–9.CrossRefPubMedPubMedCentral
23.
go back to reference Spauwen PJ, Murphy RA, Jónsson PV, Sigurdsson S, Garcia ME, Eiriksdottir G, et al. Associations of fat and muscle tissue with cognitive status in older adults: the AGES-Reykjavik Study. Age Ageing. 2017;46(2):250–7.CrossRefPubMedPubMedCentral Spauwen PJ, Murphy RA, Jónsson PV, Sigurdsson S, Garcia ME, Eiriksdottir G, et al. Associations of fat and muscle tissue with cognitive status in older adults: the AGES-Reykjavik Study. Age Ageing. 2017;46(2):250–7.CrossRefPubMedPubMedCentral
24.
go back to reference Subramaniapillai S, Suri S, Barth C, Maximov II, Voldsbekk I, van der Meer D, et al. Sex- and age-specific associations between cardiometabolic risk and white matter brain age in the UK Biobank cohort. Hum Brain Mapp. 2022;43(12):3759–74.CrossRefPubMedPubMedCentral Subramaniapillai S, Suri S, Barth C, Maximov II, Voldsbekk I, van der Meer D, et al. Sex- and age-specific associations between cardiometabolic risk and white matter brain age in the UK Biobank cohort. Hum Brain Mapp. 2022;43(12):3759–74.CrossRefPubMedPubMedCentral
25.
go back to reference Kim EH, Kim HK, Lee MJ, Bae SJ, Choe J, Jung CH, et al. Sex differences of Visceral Fat Area and visceral-to-subcutaneous Fat ratio for the risk of Incident Type 2 diabetes Mellitus. Diabetes Metab J. 2022;46(3):486–98.CrossRefPubMed Kim EH, Kim HK, Lee MJ, Bae SJ, Choe J, Jung CH, et al. Sex differences of Visceral Fat Area and visceral-to-subcutaneous Fat ratio for the risk of Incident Type 2 diabetes Mellitus. Diabetes Metab J. 2022;46(3):486–98.CrossRefPubMed
26.
go back to reference Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004;53(8):2087–94.CrossRefPubMed Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004;53(8):2087–94.CrossRefPubMed
27.
go back to reference Yoon DH, Choi SH, Yu JH, Ha JH, Ryu SH, Park DH. The relationship between visceral adiposity and cognitive performance in older adults. Age Ageing. 2012;41(4):456–61.CrossRefPubMed Yoon DH, Choi SH, Yu JH, Ha JH, Ryu SH, Park DH. The relationship between visceral adiposity and cognitive performance in older adults. Age Ageing. 2012;41(4):456–61.CrossRefPubMed
28.
go back to reference Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol. 2003;86(3–5):225–30.CrossRefPubMed Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol. 2003;86(3–5):225–30.CrossRefPubMed
29.
go back to reference Meyer MR, Clegg DJ, Prossnitz ER, Barton M. Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol (Oxf). 2011;203(1):259–69.CrossRefPubMed Meyer MR, Clegg DJ, Prossnitz ER, Barton M. Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol (Oxf). 2011;203(1):259–69.CrossRefPubMed
30.
go back to reference Vosberg DE, Parker N, Shin J, Pausova Z, Paus T. The genetics of testosterone contributes to femaleness/maleness of cardiometabolic traits and type 2 diabetes. Int J Obes (Lond). 2022;46(1):235–7.CrossRefPubMed Vosberg DE, Parker N, Shin J, Pausova Z, Paus T. The genetics of testosterone contributes to femaleness/maleness of cardiometabolic traits and type 2 diabetes. Int J Obes (Lond). 2022;46(1):235–7.CrossRefPubMed
31.
go back to reference Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO Consensus Statement. Obes Facts. 2022;15(3):321–35.CrossRefPubMedPubMedCentral Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO Consensus Statement. Obes Facts. 2022;15(3):321–35.CrossRefPubMedPubMedCentral
Metadata
Title
Correlation between fat-to-muscle mass ratio and cognitive impairment in elderly patients with type 2 diabetes mellitus: a cross-sectional study
Authors
Fan Wu
Yanlan Liu
Chenying Lin
Nahal Haghbin
Longfei Xia
Yaoshuang Li
Tong Chen
Huina Qiu
Weiran Jiang
Jingbo Li
Jingna Lin
Publication date
01-12-2024
Publisher
BioMed Central
Keyword
Type 2 Diabetes
Published in
BMC Geriatrics / Issue 1/2024
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-024-04941-2

Other articles of this Issue 1/2024

BMC Geriatrics 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine